Pure Global Unveils Industry's First Medical Device Export Index as a Benchmark for Chinese Enterprises Going Global

On September 16–17, 2022, at the 2022 China Medical Device Global Expansion Conference hosted by VCBeat VB100,PureCert Officially Launches the [Top 100 Main List of Overseas Expansion Index for Chinese Medical Device Companies] and the [Overseas Expansion Index Lists for Sub-sectors of the Chinese Medical Device Industry], this is an innovative initiative within China’s medical device industry. It conducts an in-depth, industry-level identification of domestic medical device manufacturers that serve as bellwethers for overseas expansion, enabling a more intuitive understanding of their market presence and strategic layouts in international markets.

PureReg, as a global leading SaaS+Data life sciences service provider, has always been committed to efficiently empowering Chinese medical device manufacturers aiming to expand into overseas markets. In addition to its industry-recognized multi-country registration and global clinical resource projects, PureReg has leveraged its self-developed Global Regulatory Intelligence Platform (GRIP) to differentiate itself from traditional medical device CROs, accelerating its transition into the fast lane of digitalization and intelligence.The Global Expansion Index Ranking is a proud application and implementation of PureDiagnostics’ big data platform, enhancing PureDiagnostics’ credibility within the industry.

The newly released [Top 100 List of Chinese Medical Device Enterprises Going Global] leverages massive data collected from public sources on the GRIP platform to quantitatively analyze and rank all 304 medical device manufacturers listed on China’s A-share market across five key dimensions: overseas registration, R&D capabilities, clinical strength, patents and software copyrights, and revenue performance.

PureCert strives to evaluate the global expansion capabilities of various enterprises as comprehensively as possible, and hopes that the release of this index will subtly boost the confidence of domestic manufacturers in “going global.” The companies featured in the TOP 100 main list are industry pioneers who dare to venture forth and embrace challenges; their performance will positively encourage the domestic industry to actively explore overseas markets and expand their competitive advantages.

Scan the QR code below,

View the full Top 100 list ↓↓↓

In addition to the main ranking, Puchun Chunzheng has also launched the [China Medical Device Sub-sector Overseas Expansion Index], releasing corresponding rankings for five specific dimensions: U.S. FDA registration, UK MHRA registration, Australian TGA registration, clinical trials, and patent applications.

The five specialized sub-rankings are consistent with the TOP 100 main ranking, leveraging the design model and logic of the primary index. They feature customized rankings of Chinese medical device manufacturers’ global expansion in various specialized fields, based on their registration status in major overseas markets, as well as their clinical trials and patent applications.

Subcategory Rankings - U.S. FDA Registration

Subcategory Rankings - UK MHRA Registration

Subcategory Rankings - Australian TGA Registration

Subcategory Rankings - Clinical Trials

Subcategory Rankings - Patent Applications

The newly released “Top 100 List of Chinese Medical Device Enterprises’ Overseas Expansion Index” and the “Subsector-Specific Overseas Expansion Index Lists for Chinese Medical Device Companies” represent PureCert’s effort to provide a perspective and benchmark that enable stakeholders to gain a more intuitive understanding of how domestic medical device manufacturers are positioning themselves in overseas markets. This initiative also maximally projects PureCert’s brand image as a digital enabler for the medical device industry.

Catalyzed by the COVID-19 pandemic and intensified by centralized volume-based procurement, China’s fiercely competitive medical device companies are expanding overseas to seek new opportunities. However, global expansion is not without its challenges. In this new era, going global requires not only innovation but also the adoption of digital and intelligent solutions to gain a competitive edge and achieve long-term success. The road ahead is long, but we believe that time will serve as a filter, leaving behind only the classics. This holds true for the Overseas Expansion Index, and likewise for Chinese medical device companies venturing into the global market.。